EP 1411939 A2 20040428 - GABA A-RECEPTOR-MODULATORS HAVING NMDA-ANTAGONISTIC ACTIVITY
Title (en)
GABA A-RECEPTOR-MODULATORS HAVING NMDA-ANTAGONISTIC ACTIVITY
Title (de)
BETACARBOLINDERIVATE ALS GABA A-REZEPTOR-MODULATOREN MIT NMDA-ANTAGONISTISCHER AKTIVITAET ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
Title (fr)
MODULATEURS DU RECEPTEUR GABA A A ACTIVITE ANTAGONISTE NMDA
Publication
Application
Priority
- DE 10136842 A 20010723
- EP 0208166 W 20020722
Abstract (en)
[origin: WO03011264A2] The invention relates to the use of GABAA receptor modulators having NMDA-antagonistic activity for the production of a medicament for neuroprotection and the combination of GABAA receptor modulators having NMDA-antagonistic effects and alpha -liponic acid or dihydro- alpha -liponic acid.
IPC 1-7
IPC 8 full level
A61K 31/437 (2006.01); C07D 471/04 (2006.01); A61K 31/385 (2006.01); A61K 45/00 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 31/385 (2013.01); A61K 31/437 (2013.01); A61P 25/00 (2017.12); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 03011264A2
Citation (examination)
- WO 0185149 A2 20011115 - UNIV VIRGINIA [US], et al
- BAHRAM ET AL, EUR.J.PHARM., vol. 415, no. 2-3, 2001, pages 135 - 140
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03011264 A2 20030213; WO 03011264 A3 20031204; AU 2002333262 A1 20030217; DE 10136842 A1 20030213; EP 1411939 A2 20040428; JP 2004537567 A 20041216
DOCDB simple family (application)
EP 0208166 W 20020722; AU 2002333262 A 20020722; DE 10136842 A 20010723; EP 02791466 A 20020722; JP 2003516495 A 20020722